1. Unexpected diagnosis of multiple sclerosing pneumocytomas in a patient with chondrosarcoma of the hand.
- Author
-
Van Laer SL, Vandendriessche A, Somville J, and Van Schil PE
- Subjects
- Aged, Bone Neoplasms pathology, Bone Neoplasms surgery, Chondrosarcoma secondary, Chondrosarcoma surgery, Female, Humans, Lung Neoplasms pathology, Lung Neoplasms secondary, Lung Neoplasms surgery, Magnetic Resonance Imaging, Multiple Pulmonary Nodules pathology, Multiple Pulmonary Nodules surgery, Neoplasm Recurrence, Local surgery, Neoplasms, Multiple Primary pathology, Neoplasms, Multiple Primary surgery, Pneumonectomy, Positron Emission Tomography Computed Tomography, Pulmonary Sclerosing Hemangioma pathology, Pulmonary Sclerosing Hemangioma surgery, Thoracotomy, Tomography, X-Ray Computed, Bone Neoplasms diagnosis, Chondrosarcoma diagnosis, Lung Neoplasms diagnosis, Metacarpal Bones, Multiple Pulmonary Nodules diagnosis, Neoplasms, Multiple Primary diagnosis, Pulmonary Sclerosing Hemangioma diagnosis
- Abstract
Sclerosing pneumocytomas are rare, benign pulmonary neoplasms that predominantly affect Asian female patients in the age category of 40-70 years, mostly non-smokers. We report on a 72-year-old Caucasian woman with chondrosarcoma of the hand who developed multiple bilateral progressive lung nodules suspicious of lung metastases. Staged lung resections were performed, and pathological diagnosis was confirmed by immunohistochemical analysis of the resected specimens. Next-generation sequencing (NGS) was used to detect gene mutations. Immunohistochemistry demonstrated sclerosing pneumocytomas, and NGS showed an IDH1 mutation. Eventually, the patient developed lung metastases for which rethoracotomy was performed. The differentiation of sclerosing pneumocytoma from lung cancer is a diagnostic challenge, and sclerosing pneumocytoma should be considered in the differential diagnosis of pulmonary nodules. Gene mutation analysis does not always show classical and common mutations, which should be kept in mind when interpreting its results., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF